Image analysis software developer Perspectum Diagnostics said its new partnership with pathology services provider ProPath will enable pharmaceutical companies to receive both pathology and imaging interpretation services for liver disease clinical trials from one contract research organization.
Both services will be available over a single cloud-based platform, according to Perspectum. The firm said the alliance will also support its initiative to develop a digital pathology package.
